Functional alterations of rabbit erythrocytes induced by Loxosceles gaucho venom

Human and Experimental Toxicology

Volumn 26, Issue 10, 2007, Pages 817-821

  Barretto, Orlando Cesar De Oliveira ^a,b   Prestes, Karina Soeiro ^a   Fonseca, Lorena Kessia Figueiredo ^a   Silveira, Paulo Augusto Achucarro ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b University of Sao Paulo Medical School ^*  (Brazil)

Author keywords

L gaucho envenomation; Loxosceles gaucho; Loxoscelism; Rabitt erythrocytes

Indexed keywords

LOXOSCELES GAUCHO VENOM; MEMBRANE PROTEIN; SPIDER VENOM; UNCLASSIFIED DRUG;

ANALYSIS OF VARIANCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; ENVENOMATION; ERYTHROCYTE; HEMOLYSIS; IN VIVO STUDY; MALE; NONHUMAN; OSMOTIC FRAGILITY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; RABBIT; SPIDER BITE;

ANIMALS; ERYTHROCYTES; MALE; OSMOTIC FRAGILITY; PHOSPHORIC DIESTER HYDROLASES; RABBITS; SPIDER VENOMS;

ARANEAE; CAVIA; LOXOSCELES GAUCHO; ORYCTOLAGUS CUNICULUS; SUIDAE;

EID: 36849081323     PISSN: 09603271     EISSN: None     Source Type: Journal    
DOI: 10.1177/0960327107084070     Document Type: Article

References (19)

1. Ministry of Health. Manual de diagnóstico e tratamento de acidentes peçonhentos. Brasilia: Ministério da Saúde, Fundacao Nacional de Saude/Coordenacao de Controle de Zoonoses e Animais Peçonhentos, 1998.
2. Futrell JM, Morgan BB, Morgan PN. An in vitro model for studying hemolysis associated with venom from the brown recluse spider (Loxosceles reclusa). Toxicon 1979; 17: 355-62.
3. Tavares FL, Souza-e-Silva MCC, Santoro ML, Barbaro KC, Rebechi IMM, Sano-Martins IS. Changes in hematological, hemostatic and biochemical parameters induced experimentallly in rabbits by Loxosceles gaucho spider venom. Hum Exp Toxicol 2004; 23: 477-86.
4. Bücherl W. Biology and venoms of the most important South American spiders of the genera Phoneutria, Loxosceles, Lycosa and Latrodectus. Am Zool 1969; 9: 157-9.
5. Barbaro KC, Cardoso JL, Eickstedt VR, Mota I. Dermonecrotic and lethal components of Loxosceles gaucho spider venom. Toxicon 1992; 30: 331-8.
6. Parpart AK, Lorenzi PB, Parpart ER, Gregg JR, Chase AM. The osmotic resistance (fragility) of human red cells. J Clin Invest 1947; 26: 636-40.
7. Mohandas N, Chasis JA. Red blood cell deformability, membrane material properties and shape: Regulation by transmembrane, skeletal and cytosolic proteins and lipids. Semin Hematol 1993; 30: 171-92.
8. Palek J. The red cell membrane. In Beutler E, Lichtman MA, Coller BS, Kipps TJ, eds. Williams Heamatology, McGraw-Hill Inc., 1995, 406-16.
9. Barretto OCdeO, Satake M, Nonoyama K, Cardoso JLC. The calcium-dependent protease of Loxosceles gaucho venom acts preferentially upon red cell band 3 transmembrane protein. Braz J Med Biol Res 2003; 36: 309-13.
10. Tambourgi DV, Magnoli FC, von Eickstedt VR, Benedetti ZC, Petricevich VL, da Silva WD. Incorporation of a 35-kilodalton purified protein from Loxosceles intermedia spider venom transforms human erythrocytes into activators of autologous complement alternative pathway. J Immunol 1995; 155: 4459-66
11. Pangburn MK, Muller-Eberhard HJ. Complement c3 convertase: cell surface restriction of β1 h control and generation of restriction on neuraminidase-treated cells. Proc Nat Acad Sci of USA 1978; 75: 2416-20.
12. Fearon DT. Regulation by membrane sialic acid of β1 h-dependent decay-dissociation of amplification c3 convertase of the alternative complement pathway. Proc Nat Acad Sci USA 1978; 75: 1971-5.
13. Wang RH, Phillips GR Jr, Medof ME et al. Activation of the alternative complement pathway by exposure of phosphatidylethanolamine and phosphatidylserine on erythrocytes from sickle cell disease patients. J Clin Invest 1993; 92: 1326-35.
14. Kraus D, Medof ME, Mold C. Complementary recognition of alternative pathway activators by decay-accelerating factor and factor h. Infect Immunity 1998; 66: 399-405.
15. Tambourgi DV, De Souza Da Silva MS, Billington SJ, Goncalves de Andrade RM, Magnoli FC, Songer JG, Van Den Berg CW. Mechanism of induction of complement susceptibility of erythrocytes by spider and bacterial sphingomyelinases. Immunity 2002; 107: 93-101.
16. Rauenbuehler PB, Cordes KA, Salhany IM. Identification of the hemoglobin binding sites on the inner surface of the erythrocyte membrane. Biochem Biophys Acta 1982; 692: 361-70.
17. Ligi F, Ciacci C, Palma F, Palma F. Comparative study of the cytoplasmic domain of band 3 from human and rabbit erythrocyte membranes. Comp Biochem Physiol B: Biochem Mol Biol 1998; 121: 265-71.
18. Wessels JM, Veerkamp JH. Some aspects of the osmotic lysis of erythrocytes.3. Comparison of the glycerol permeability and lipid composition of red blood cell membranes from eight mammalian species. Biochem Biophys Acta 1973; 291: 190-6.
19. Barretto OCdeO, Cardoso JL, De Cillo D. Viscerocutaneous form of loxoscelism and glucose-6-phosphate dehydrogenase deficiency. Rev Inst Med Trop São Paulo 1985; 27: 264-67.